Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Midwest Professional Planners LTD.

Midwest Professional Planners LTD. raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,033 shares of the medical equipment provider’s stock after acquiring an additional 100 shares during the quarter. Midwest Professional Planners LTD.’s holdings in Intuitive Surgical were worth $1,583,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in ISRG. Massachusetts Financial Services Co. MA acquired a new position in Intuitive Surgical in the third quarter valued at $558,807,000. Proficio Capital Partners LLC increased its stake in Intuitive Surgical by 89,098.8% in the fourth quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock valued at $495,845,000 after purchasing an additional 948,902 shares during the last quarter. FMR LLC increased its stake in Intuitive Surgical by 8.3% in the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after purchasing an additional 838,793 shares during the last quarter. Raymond James Financial Inc. acquired a new stake in Intuitive Surgical during the fourth quarter worth about $313,769,000. Finally, Wilmington Savings Fund Society FSB increased its stake in Intuitive Surgical by 15,322.2% during the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after acquiring an additional 552,058 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Intuitive Surgical

In related news, EVP Brian Edward Miller sold 8,900 shares of the firm’s stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total value of $4,317,123.00. Following the sale, the executive vice president now directly owns 5,758 shares in the company, valued at $2,793,033.06. This trade represents a 60.72 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 22,209 shares of company stock worth $11,928,127. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Trading Down 4.1 %

Shares of Intuitive Surgical stock opened at $476.78 on Friday. The business’s 50 day simple moving average is $568.47 and its 200-day simple moving average is $531.22. The stock has a market capitalization of $169.82 billion, a price-to-earnings ratio of 74.38, a PEG ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the company. Truist Financial upped their price target on Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. JPMorgan Chase & Co. upped their target price on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Wells Fargo & Company upped their target price on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Leerink Partners upped their target price on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Finally, Piper Sandler reaffirmed an “overweight” rating and issued a $670.00 target price (up previously from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. One analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.